_id
69148136ccc777a4e85d9300
Ticker
NEXI
Name
Neximmune Inc
Exchange
PINK
Address
9119 Gaither Road, Gaithersburg, MD, United States, 20877
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.neximmune.com
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Last Close
0.0001
Volume
100
Current Price
0.0001
Change
0
Last Updated
2026-01-05T11:20:13.999Z
Image
-
Ipo Date
2021-02-12T00:00:00.000Z
Market Cap
139
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
2
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2024-06-30
Revenue
0
Cost Of Revenue
75408
Gross Profit
-75408
Operating Expenses
3509306
Operating Income
-3509306
Interest Expense
-
Pretax Income
-2326765
Net Income
-2326765
Eps
-1.6855791277134444
Dividends Per Share
-
Shares Outstanding
1394671
Income Tax Expense
-75408
EBITDA
-2654459
Operating Margin
-
Total Other Income Expense Net
1182541
Cash
2424112
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
3126863
Property Plant Equipment
1106608
Total Assets
5861300
Payables
1281161
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4940761
Equity
920539
Bs_currency_symbol
USD
Depreciation
114912
Change In Working Capital
259620
Cash From Operations
-2072362
Capital Expenditures
0
Cash From Investing
43576
Cash From Financing
3143949
Net Change In Cash
-2028786
Cf_currency_symbol
USD
PE
-
PB
0.00014995508066469753
ROE
-252.76115406300005
ROA
-39.69708085237064
FCF
-2072362
Fcf Percent
-
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
4
Quality Investing Score
1
Value Investing Score
5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
75408
Quarters > 0 > income Statement > gross Profit
-75408
Quarters > 0 > income Statement > operating Expenses
3509306
Quarters > 0 > income Statement > operating Income
-3509306
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2326765
Quarters > 0 > income Statement > net Income
-2326765
Quarters > 0 > income Statement > eps
-1.6855791277134444
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1380395
Quarters > 0 > income Statement > income Tax Expense
-75408
Quarters > 0 > income Statement > EBITDA
-2654459
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1182541
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2424112
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3126863
Quarters > 0 > balance Sheet > property Plant Equipment
1106608
Quarters > 0 > balance Sheet > total Assets
5861300
Quarters > 0 > balance Sheet > payables
1281161
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4940761
Quarters > 0 > balance Sheet > equity
920539
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2326765
Quarters > 0 > cash Flow > depreciation
114912
Quarters > 0 > cash Flow > change In Working Capital
259620
Quarters > 0 > cash Flow > cash From Operations
-2072362
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
43576
Quarters > 0 > cash Flow > cash From Financing
3143949
Quarters > 0 > cash Flow > net Change In Cash
-2028786
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.6855791277134444
Quarters > 0 > ratios > PB
0.00014995508066469753
Quarters > 0 > ratios > ROE
-252.76115406300005
Quarters > 0 > ratios > ROA
-39.69708085237064
Quarters > 0 > ratios > FCF
-2072362
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
2120558
Quarters > 1 > income Statement > cost Of Revenue
114912
Quarters > 1 > income Statement > gross Profit
-114912
Quarters > 1 > income Statement > operating Expenses
2642554
Quarters > 1 > income Statement > operating Income
-2757470
Quarters > 1 > income Statement > interest Expense
260332000
Quarters > 1 > income Statement > pretax Income
-3077273
Quarters > 1 > income Statement > net Income
-3077273
Quarters > 1 > income Statement > eps
-2.4608380021399476
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1250498
Quarters > 1 > income Statement > income Tax Expense
-45436
Quarters > 1 > income Statement > EBITDA
-2642554
Quarters > 1 > income Statement > operating Margin
-130.03511339939772
Quarters > 1 > income Statement > total Other Income Expense Net
-319807
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
4472898
Quarters > 1 > balance Sheet > short Term Investments
1444043
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6042023
Quarters > 1 > balance Sheet > property Plant Equipment
1237989
Quarters > 1 > balance Sheet > total Assets
8990613
Quarters > 1 > balance Sheet > payables
771614
Quarters > 1 > balance Sheet > short Term Debt
137618
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6023851
Quarters > 1 > balance Sheet > equity
2966762
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3077273
Quarters > 1 > cash Flow > depreciation
114912
Quarters > 1 > cash Flow > change In Working Capital
-205453
Quarters > 1 > cash Flow > cash From Operations
-2416058
Quarters > 1 > cash Flow > capital Expenditures
48671280
Quarters > 1 > cash Flow > cash From Investing
522555
Quarters > 1 > cash Flow > cash From Financing
3143949
Quarters > 1 > cash Flow > net Change In Cash
1250446
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-2.4608380021399476
Quarters > 1 > ratios > PB
0.000042150263485914945
Quarters > 1 > ratios > ROE
-103.72497018635131
Quarters > 1 > ratios > ROA
-34.227621631583965
Quarters > 1 > ratios > FCF
-51087338
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-24.091459889331016
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
4677019
Quarters > 2 > income Statement > operating Income
-4677019
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-5358625
Quarters > 2 > income Statement > net Income
-5358625
Quarters > 2 > income Statement > eps
-5.025344174356666
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1066320
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-727042
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3202452
Quarters > 2 > balance Sheet > short Term Investments
1444043
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5400959
Quarters > 2 > balance Sheet > property Plant Equipment
1399617
Quarters > 2 > balance Sheet > total Assets
8593949
Quarters > 2 > balance Sheet > payables
1336318
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5084232
Quarters > 2 > balance Sheet > equity
3509717
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5358625
Quarters > 2 > cash Flow > depreciation
228509
Quarters > 2 > cash Flow > change In Working Capital
-2103195
Quarters > 2 > cash Flow > cash From Operations
-5832758
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-5832758
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-5.025344174356666
Quarters > 2 > ratios > PB
0.000030381936777238733
Quarters > 2 > ratios > ROE
-152.67968898916922
Quarters > 2 > ratios > ROA
-62.35346521139466
Quarters > 2 > ratios > FCF
-5832758
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
265542
Quarters > 3 > income Statement > gross Profit
-265542
Quarters > 3 > income Statement > operating Expenses
9995767
Quarters > 3 > income Statement > operating Income
-9995767
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9854187
Quarters > 3 > income Statement > net Income
-9854187
Quarters > 3 > income Statement > eps
-9.404007745228181
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1047871
Quarters > 3 > income Statement > income Tax Expense
-265542
Quarters > 3 > income Statement > EBITDA
-7624710
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1963937
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
9000210
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
39009
Quarters > 3 > balance Sheet > inventories
-39009
Quarters > 3 > balance Sheet > total Current Assets
10320218
Quarters > 3 > balance Sheet > property Plant Equipment
4241476
Quarters > 3 > balance Sheet > total Assets
14561694
Quarters > 3 > balance Sheet > payables
737494
Quarters > 3 > balance Sheet > short Term Debt
501811
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6307506
Quarters > 3 > balance Sheet > equity
8254188
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9854187
Quarters > 3 > cash Flow > depreciation
265542
Quarters > 3 > cash Flow > change In Working Capital
1035227
Quarters > 3 > cash Flow > cash From Operations
-7284057
Quarters > 3 > cash Flow > capital Expenditures
981
Quarters > 3 > cash Flow > cash From Investing
3247
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-7280810
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-9.404007745228181
Quarters > 3 > ratios > PB
0.00001269502221175481
Quarters > 3 > ratios > ROE
-119.38408720518603
Quarters > 3 > ratios > ROA
-67.67198239435605
Quarters > 3 > ratios > FCF
-7285038
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1024972
Annuals > 0 > income Statement > gross Profit
-1024972
Annuals > 0 > income Statement > operating Expenses
28167510
Annuals > 0 > income Statement > operating Income
-29192480
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-32344392
Annuals > 0 > income Statement > net Income
-32344392
Annuals > 0 > income Statement > eps
-30.819798221575123
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1049468
Annuals > 0 > income Statement > income Tax Expense
-2
Annuals > 0 > income Statement > EBITDA
-28167510
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-3151912
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3202452
Annuals > 0 > balance Sheet > short Term Investments
1444043
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5400959
Annuals > 0 > balance Sheet > property Plant Equipment
1399617
Annuals > 0 > balance Sheet > total Assets
8593949
Annuals > 0 > balance Sheet > payables
1336318
Annuals > 0 > balance Sheet > short Term Debt
137618
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5084232
Annuals > 0 > balance Sheet > equity
3509717
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-32344393
Annuals > 0 > cash Flow > depreciation
1024972
Annuals > 0 > cash Flow > change In Working Capital
-4878284
Annuals > 0 > cash Flow > cash From Operations
-31430396
Annuals > 0 > cash Flow > capital Expenditures
48720
Annuals > 0 > cash Flow > cash From Investing
-44492
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
-31474888
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-30.819798221575123
Annuals > 0 > ratios > PB
0.00002990178410396052
Annuals > 0 > ratios > ROE
-921.5669525491655
Annuals > 0 > ratios > ROA
-376.3623917246891
Annuals > 0 > ratios > FCF
-31479116
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1495345
Annuals > 1 > income Statement > gross Profit
-1495345
Annuals > 1 > income Statement > operating Expenses
61587544
Annuals > 1 > income Statement > operating Income
-63082889
Annuals > 1 > income Statement > interest Expense
576690000
Annuals > 1 > income Statement > pretax Income
-62506199
Annuals > 1 > income Statement > net Income
514183801
Annuals > 1 > income Statement > eps
534.2924309305004
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
962364
Annuals > 1 > income Statement > income Tax Expense
-576690000
Annuals > 1 > income Statement > EBITDA
-61010852
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
576691
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
34642340
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
74467
Annuals > 1 > balance Sheet > inventories
-19467
Annuals > 1 > balance Sheet > total Current Assets
37368751
Annuals > 1 > balance Sheet > property Plant Equipment
5426103
Annuals > 1 > balance Sheet > total Assets
43059824
Annuals > 1 > balance Sheet > payables
2377374
Annuals > 1 > balance Sheet > short Term Debt
599047
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10759340
Annuals > 1 > balance Sheet > equity
32300484
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-62506199
Annuals > 1 > cash Flow > depreciation
994792
Annuals > 1 > cash Flow > change In Working Capital
3929437
Annuals > 1 > cash Flow > cash From Operations
-51190920
Annuals > 1 > cash Flow > capital Expenditures
1255116
Annuals > 1 > cash Flow > cash From Investing
50315744
Annuals > 1 > cash Flow > cash From Financing
5178664
Annuals > 1 > cash Flow > net Change In Cash
4303488
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
534.2924309305004
Annuals > 1 > ratios > PB
0.000002979410463323088
Annuals > 1 > ratios > ROE
1591.876459188661
Annuals > 1 > ratios > ROA
1194.1149620119209
Annuals > 1 > ratios > FCF
-52446036
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
60
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
870285
Annuals > 2 > income Statement > gross Profit
-870285
Annuals > 2 > income Statement > operating Expenses
52385497
Annuals > 2 > income Statement > operating Income
-53255782
Annuals > 2 > income Statement > interest Expense
905326
Annuals > 2 > income Statement > pretax Income
-50901508
Annuals > 2 > income Statement > net Income
-51745427
Annuals > 2 > income Statement > eps
-56.6665794234501
Annuals > 2 > income Statement > dividends Per Share
377562
Annuals > 2 > income Statement > shares Outstanding
913156
Annuals > 2 > income Statement > income Tax Expense
843919
Annuals > 2 > income Statement > EBITDA
-49125900
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2354272
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
30326352
Annuals > 2 > balance Sheet > short Term Investments
51491942
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
86280710
Annuals > 2 > balance Sheet > property Plant Equipment
4427307
Annuals > 2 > balance Sheet > total Assets
91032116
Annuals > 2 > balance Sheet > payables
1045159
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7271449
Annuals > 2 > balance Sheet > equity
83760667
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-50901508
Annuals > 2 > cash Flow > depreciation
870285
Annuals > 2 > cash Flow > change In Working Capital
654570
Annuals > 2 > cash Flow > cash From Operations
-45785071
Annuals > 2 > cash Flow > capital Expenditures
2350416
Annuals > 2 > cash Flow > cash From Investing
-53807281
Annuals > 2 > cash Flow > cash From Financing
124887625
Annuals > 2 > cash Flow > net Change In Cash
25295273
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-56.6665794234501
Annuals > 2 > ratios > PB
0.0000010901966671301697
Annuals > 2 > ratios > ROE
-61.77771602511236
Annuals > 2 > ratios > ROA
-56.84304537093261
Annuals > 2 > ratios > FCF
-48135487
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
618990
Annuals > 3 > income Statement > gross Profit
-618990
Annuals > 3 > income Statement > operating Expenses
27232443
Annuals > 3 > income Statement > operating Income
-27851433
Annuals > 3 > income Statement > interest Expense
1682894
Annuals > 3 > income Statement > pretax Income
-29865997
Annuals > 3 > income Statement > net Income
-31638668
Annuals > 3 > income Statement > eps
-34.75588892147849
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
910311
Annuals > 3 > income Statement > income Tax Expense
1772671
Annuals > 3 > income Statement > EBITDA
-27564110
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-2014567
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5031079
Annuals > 3 > balance Sheet > short Term Investments
1006878000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
8392437
Annuals > 3 > balance Sheet > property Plant Equipment
2885260
Annuals > 3 > balance Sheet > total Assets
11301070
Annuals > 3 > balance Sheet > payables
2760129
Annuals > 3 > balance Sheet > short Term Debt
19117664
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
27055262
Annuals > 3 > balance Sheet > equity
-15754192
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-29865997
Annuals > 3 > cash Flow > depreciation
618990
Annuals > 3 > cash Flow > change In Working Capital
-89431
Annuals > 3 > cash Flow > cash From Operations
-26404701
Annuals > 3 > cash Flow > capital Expenditures
864659
Annuals > 3 > cash Flow > cash From Investing
221936
Annuals > 3 > cash Flow > cash From Financing
22084857
Annuals > 3 > cash Flow > net Change In Cash
-4097908
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-34.75588892147849
Annuals > 3 > ratios > PB
-0.00000577821445872946
Annuals > 3 > ratios > ROE
200.82697989208205
Annuals > 3 > ratios > ROA
-279.96170274142185
Annuals > 3 > ratios > FCF
-27269360
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-1.6855791277134444
Valuation > metrics > PB
0.00014995508066469753
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-252.76115406300005
Profitability > metrics > ROA
-74.41211847145206
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
5.367247884120064
Risk > metrics > Interest Coverage
-10.709094460075558
Risk > final Score
-37
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.4406479747666374
Liquidity > metrics > Quick Ratio
2.4406479747666374
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
18
Prev Risks > 1
4
Prev Risks > 2
30
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:16:33.163Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-08-07
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-1.6856
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-04-16
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-2.4608
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-02-07
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-5.0253
Earnings History > 2 > eps Estimate
-0.06
Earnings History > 2 > eps Difference
-4.9653
Earnings History > 2 > surprise Percent
-8275.5
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-11-17
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-235.1002
Earnings History > 3 > eps Estimate
-7.5
Earnings History > 3 > eps Difference
-227.6002
Earnings History > 3 > surprise Percent
-3034.6693
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-08-10
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.29
Earnings History > 4 > eps Estimate
-0.29
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-05-15
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.37
Earnings History > 5 > eps Estimate
-0.46
Earnings History > 5 > eps Difference
0.09
Earnings History > 5 > surprise Percent
19.5652
Earnings History > 6 > period
2022-12-31
Earnings History > 6 > report Date
2023-03-28
Earnings History > 6 > date
2022-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.7
Earnings History > 6 > eps Estimate
-0.51
Earnings History > 6 > eps Difference
-0.19
Earnings History > 6 > surprise Percent
-37.2549
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-14
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.6
Earnings History > 7 > eps Estimate
-0.69
Earnings History > 7 > eps Difference
0.09
Earnings History > 7 > surprise Percent
13.0435
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-08-15
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.69
Earnings History > 8 > eps Estimate
-0.68
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-1.4706
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-05-12
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.66
Earnings History > 9 > eps Estimate
-0.7
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
5.7143
Earnings History > 10 > period
2021-12-31
Earnings History > 10 > report Date
2022-03-09
Earnings History > 10 > date
2021-12-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.69
Earnings History > 10 > eps Estimate
-0.78
Earnings History > 10 > eps Difference
0.09
Earnings History > 10 > surprise Percent
11.5385
Earnings History > 11 > period
2021-09-30
Earnings History > 11 > report Date
2021-11-12
Earnings History > 11 > date
2021-09-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.65
Earnings History > 11 > eps Estimate
-0.64
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-1.5625
Earnings History > 12 > period
2021-06-30
Earnings History > 12 > report Date
2021-08-09
Earnings History > 12 > date
2021-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.54
Earnings History > 12 > eps Estimate
-0.51
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-5.8824
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-05-17
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.71
Earnings History > 13 > eps Estimate
-0.66
Earnings History > 13 > eps Difference
-0.05
Earnings History > 13 > surprise Percent
-7.5758
Earnings History > 14 > period
2020-12-31
Earnings History > 14 > report Date
2021-02-11
Earnings History > 14 > date
2020-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.13
Earnings History > 14 > eps Estimate
-0.44
Earnings History > 14 > eps Difference
-0.69
Earnings History > 14 > surprise Percent
-156.8182
Earnings History > 15 > period
2019-09-30
Earnings History > 15 > report Date
2019-12-31
Earnings History > 15 > date
2019-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-4.6607
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-4.6607
Earnings History > 15 > surprise Percent
-
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AA Look At Nexi (BIT:NEXI) Valuation As Efficiency Efforts And Consolidation Rumors Draw Investor Focus simplywall.st
Read more →Is Nexi (BIT:NEXI) Tightening Costs To Defend Its Moat Or Mask Strategic Uncertainty? simplywall.st
Read more →Showing 2 of 10
(Last Updated 2024-06-30)
Rating:
HOLD
Target Price:
$2
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 5.08% of the total shares of Neximmune Inc
1.
Sabby Management LLC(3.5782%)
since
2024/06/30
2.
Raymond James & Associates(0.7747%)
since
2024/09/30
3.
JPMorgan Chase & Co(0.2868%)
since
2024/06/30
4.
Comerica Bank(0.2335%)
since
2024/06/30
5.
Tower Research Capital LLC(0.1521%)
since
2024/06/30
6.
UBS Group AG(0.0457%)
since
2024/06/30
7.
SSgA U.S. Total Market Index Strategy(0.0033%)
since
2024/06/30
8.
BNP Paribas Arbitrage, SA(0.0029%)
since
2024/06/30
9.
Bank of America Corp(0.0005%)
since
2024/06/30
10.
Royal Bank of Canada(0%)
since
2024/06/30
11.
Wells Fargo & Co(0%)
since
2024/06/30
12.
EPIQ Capital Group, LLC(0%)
since
2024/09/30
13.
Slate Path Capital LP(0%)
since
2024/09/30
14.
Vanguard Group Inc(0%)
since
2024/09/30
15.
PNC Financial Services Group Inc(0%)
since
2024/09/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
-1.6856
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.